Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Class A Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Numerator:
Net loss	$ (7,624)		$ (13,847)
Denominator:
Net loss per Class A common share attributable to Rani Therapeutics Holding, Inc., basic	$ (0.31)		$ (0.60)
Net loss per Class A common share attributable to Rani Therapeutics Holding, Inc., diluted	$ (0.31)		$ (0.60)
Common Class A
Numerator:
Net loss	$ (7,624)		$ (13,847)
Denominator:
Weighted-average share outstanding basic	24,371		22,930
Weighted-average share outstanding diluted	24,371		22,930
Net loss per Class A common share attributable to Rani Therapeutics Holding, Inc., basic	$ (0.31)		$ (0.60)
Net loss per Class A common share attributable to Rani Therapeutics Holding, Inc., diluted	$ (0.31)		$ (0.60)